Close on 09 Oct 2026
All Indian Equities

REKVINA LABORATORIES

VINRKLBVerified
ISIN: BSE:526075 · Exchange: BSE

REKVINA LABORATORIES is a publicly traded security listed on the BSE exchange.

Sector: Diversified Indian Equities·Industry: Public Market Listed Security·Market Cap: LARGE CAP
Close on 16 Oct 2026
₹61.49
+1.60 (+2.67%)
Last updated: 16 Oct 2026 (NSE/BSE EOD settlement)

Stock Snapshot & Key Numbers — REKVINA LABORATORIES

Verified Daily Close

Official closing price, 1-year price range, valuation multiples, and market value from exchange records.

Last Session Move
Up +2.67% on 16 Oct 2026
Position vs 1-Year High
0.8% below 52W High
P/E Valuation Multiple
Not Reported / Loss
Annual Cash Dividend
0.00% / No Recent Dividend
Close on 16 Oct 2026
₹61.49
+1.60 (+2.67%)vs prev close
1-Year Low to High Range99% of range
Low: ₹5High: ₹62
Valuation (P/E, P/B & Dividend)
P/E Ratio (Price / Profit):N/A
P/B Ratio (Price / Book):N/A
Dividend Yield:0.00%
Total Company Value (Market Cap)
₹59.52 Cr
Sector: Diversified Indian Equities
Latest Official Announcement:Rekvina Laboratories accepts resignation of MD Amit Mukesh Shah - scanx.trade
1mo ago
Plain-English Company Summary

REKVINA LABORATORIES (VINRKLB) is a Indian equity security listed on the BSE with ISIN BSE:526075. As of the last recorded market session on Close on 16 Oct 2026, the stock closed at ₹61.49, recording a +1.60 (+2.67%) advance from its previous close of ₹59.89. Over the trailing 52-week trading cycle, VINRKLB has traded between a 52-week low of ₹4.50 and a 52-week high of ₹61.98, establishing its annual trading channel. In historical performance, REKVINA LABORATORIES has gained 1266.44% over the past 1 year. Period returns across standard measurement intervals include: 1-week: +14.83%, 1-month: +7.52%, 6-month: +45.4%, 1-year: +1266.44%, 3-year: +1266.44%, 5-year: +1330%. Daily reported trading volume reached 9,115 equity shares. On key valuation multiples as of 11 Oct 2026, the company trades at a trailing price-to-earnings (P/E) multiple of not meaningful (negative earnings) and a price-to-book (P/B) ratio of data unavailable, with a trailing dividend yield of 0.00%. Its market capitalization stands at ₹59.52 Cr. The company is categorized under the Diversified Indian Equities sector and Public Market Listed Security industry within the Indian equities universe.

Price Chart

1Y: +1266.44% (₹56.99)
₹62₹42₹23₹5Thu, 16 Oct, 2025Fri, 16 Oct, 2026

Trading Multiples & Ranges

Price boundaries and liquidity distribution.

52-Week Channel₹61.49
Low: ₹4.5High: ₹61.98
Day Range₹56.9 – ₹61.5
Market Cap₹59.52 Cr
Reported Volume9,115
P/E Ratio (TTM)N/M
Price-to-Book (P/B)—
Dividend Yield0.00%
Fundamentals as of 11 Oct 2026

Past Price Win/Loss Odds (1-Week, 1-Month, 3-Month)

How often this stock rose, stayed flat, or fell over past 21-day holding periods (based on historical data, not a future prediction).

1 Month Holding Period (21 trading days)
1,214 past 21-day periods analyzed
Within ±5% (86.9%)
9.3%
Fell > 5%
3.8%
46 windows
Within ±5%
86.9%
1,055 windows
Rose > 5%
9.3%
113 windows
In 80% of past 1 month windows the move was within ±0%.
Historical outcomes of this stock's own price. Not a forecast. (1235 trading days of history).
How to read historical odds

How Outside Factors Affect This Stock (Market, Crude Oil & Currency)

How closely this stock moved with the broader market index, crude oil, and the exchange rate over the past year.

Swing Rank: 50th percentile
Typical 1-Year Price Swing (Volatility): 63.2% annualized
Price Swing Level vs Market: Moderate Swings
Factor / Benchmark1Y Beta (Sensitivity)1Y Correlation (-1 to +1)What This Means
NIFTY 50-0.09-0.02Trailing 1Y historical sensitivity: a 1% move in NIFTY 50 coincided with a -0.09% co-movement (correlation: -0.02). Descriptive historical relationship, not predictive.
USD / INR-0.50-0.06Trailing 1Y historical sensitivity: a 1% move in USD / INR coincided with a -0.50% co-movement (correlation: -0.06). Descriptive historical relationship, not predictive.
Brent Crude Oil+0.06+0.05Trailing 1Y historical sensitivity: a 1% move in Brent Crude Oil coincided with a +0.06% co-movement (correlation: 0.05). Descriptive historical relationship, not predictive.
US 10Y Treasury Yield-0.16-0.04Trailing 1Y historical sensitivity: a 1% move in US 10Y Treasury Yield coincided with a -0.16% co-movement (correlation: -0.04). Descriptive historical relationship, not predictive.
How to read Beta & Correlation ( Beta > 1 = wider swings than market; < 1 = calmer )▾

Sensitivities measure historical 1-year regression beta and correlation across paired daily trading sessions over the past 252 trading days. Past relationships can shift over time and do not guarantee future co-movement.

Trailing Returns Breakdown

Calendar-aligned historical percentage performance across standard market windows.

PeriodStart PriceCurrent PriceReturn (%)
1 Week₹53.55₹61.49+14.83%
15 Days₹49.86₹61.49+23.33%
1 Month₹57.19₹61.49+7.52%
3 Months₹30.97₹61.49+98.55%
6 Months₹42.29₹61.49+45.40%
1 Year₹4.50₹61.49+1266.44%
3 Years₹4.50₹61.49+1266.44%
5 Years₹4.30₹61.49+1330.00%

Price Swings & Biggest Historical Drops

How much this stock typically fluctuates and its largest peak-to-bottom drops over 1 and 5 years.

1Y Yearly Swing
63.2%
Annualized volatility
1Y Beta vs Index
-0.10
vs benchmark index
Biggest 1Y Drop
-45.6%
1Y peak-to-low drop
Biggest 5Y Drop
-45.6%
5Y peak-to-low drop
vs 52W High
-0.8%
Distance from 1Y high
vs 52W Low
+1266.4%
Gain above 1Y low

Calendar-Year Historical Performance

Annual performance breakdown comparing first and last closing sessions of each calendar year.

Calendar YearStart CloseEnd CloseAnnual ReturnTrajectory Bar
CY 2026₹4.50₹61.49+1266.4%
CY 2025₹4.50₹4.50+0.0%
CY 2024₹4.50₹4.50+0.0%
CY 2023₹4.50₹4.50+0.0%
CY 2022₹4.50₹4.50+0.0%
CY 2021₹4.30₹4.50+4.7%

Historical Investment Simulator

Factual simulation of past returns in REKVINA LABORATORIES (VINRKLB) using real recorded closing prices.

₹1,00,000.00
5 Years
Principal Invested
₹1,00,000.00
₹1,00,000.00 starting capital
Portfolio Value Today
₹14,29,999.98
Based on latest close
Absolute Return
+1330.0%
+₹13,29,999.98
Annualized (CAGR)
+70.3%
Compound annual growth
Entry Price: ₹4.30 · Exit Price: ₹61.49
Simulated 5Y period (INR)

Corporate Actions History

No dividend or stock split distributions recorded in historical feeds for VINRKLB.

Recent News & Official Exchange Announcements

Official exchange filings, order wins, and company updates. Click any announcement to see how it affects the business on the right.

Showing 5 of 5 Updates
#1 GENERALLODR Materiality: 68/100Neutral / RoutineOngoing ImpactDirect Mention
1mo ago

Rekvina Laboratories accepts resignation of MD Amit Mukesh Shah - scanx.trade

Rekvina Laboratories accepts resignation of MD Amit Mukesh Shah scanx.trade

Valuation Impact:±0.5% (Neutral Fundamental Range)
Inspecting in Causal Panel
Source: scanx.trade·Horizon: SHORT_TERM
SEBI LODR Reg 30 Mapped
#2 EXPANSION CAPEXLODR Materiality: 84/100Positive Business DriverOngoing Impact
18d ago

Rekvina Labs AGM voting results: all 4 resolutions pass unanimously - scanx.trade

Rekvina Labs AGM voting results: all 4 resolutions pass unanimously scanx.trade

Valuation Impact:+2.0% to +4.5% (Productive Capacity Accretion)
Click to analyze
Source: scanx.trade·Horizon: LONG_TERM
SEBI LODR Reg 30 Mapped
#3 GENERALLODR Materiality: 60/100Neutral / RoutineOngoing Impact
24d ago

Rekvina Labs MD Amit Shah resigns; registered office shifts to Vadodara - scanx.trade

Rekvina Labs MD Amit Shah resigns; registered office shifts to Vadodara scanx.trade

Valuation Impact:±0.5% (Neutral Fundamental Range)
Click to analyze
Source: scanx.trade·Horizon: SHORT_TERM
SEBI LODR Reg 30 Mapped
#4 GENERALLODR Materiality: 60/100Neutral / RoutineOngoing Impact
1mo ago

Rekvina Labs accepts resignation of Company Secretary Deepak Khandelwal - scanx.trade

Rekvina Labs accepts resignation of Company Secretary Deepak Khandelwal scanx.trade

Valuation Impact:±0.5% (Neutral Fundamental Range)
Click to analyze
Source: scanx.trade·Horizon: SHORT_TERM
SEBI LODR Reg 30 Mapped
#5 GENERALLODR Materiality: 60/100Neutral / RoutineBackground Context
3mo ago

Rekvina Labs open offer at ₹10 per share opens July 1 - scanx.trade

Rekvina Labs open offer at ₹10 per share opens July 1 scanx.trade

Valuation Impact:±0.5% (Neutral Fundamental Range)
Click to analyze
Source: scanx.trade·Horizon: SHORT_TERM
SEBI LODR Reg 30 Mapped

Why This Matters for the Business

Plain-English breakdown of how the selected announcement connects to revenue, costs, and business drivers.

Event 1 of 5
Causal Attribution in Focus
GENERAL·1mo ago
Verified Exchange / Wire Disclosure:
Rekvina Laboratories accepts resignation of MD Amit Mukesh Shah - scanx.trade
Source: scanx.trade·LODR Materiality: 68/100
3-Stage Transmission Mechanism:
1. Disclosure Trigger
Regulatory & Corporate Disclosure Event
2. Sector Transmission
Sector-wide volume demand absorption & operating leverage
3. VINRKLB Accretion
±0.5% (Neutral Fundamental Range)
Causal Attribution Analysis:Direct Named Awardee

Institutional regulatory disclosure or industry observation

Extracted Factual Evidence:
  • •Verified against public financial wire feeds and exchange disclosures
P&L Operating Leverage

Volume throughput absorbs fixed manufacturing plant overheads, supporting operating EBITDA margins and cash generation across diversified indian equities units.

Order Book & Revenue Visibility

Continuous commercial tenders and capital expenditures lock in forward order book-to-bill expansion.

Affected Financial Metrics:
Enterprise Valuation MultiplesMarket Liquidity
Cross-asset macro betas (Brent Crude, USD/INR, NIFTY) are mapped in the dedicated dependency engine.
View Graph
Evidence Integrity: Hypotheses and attribution models are anchored strictly in verified regulatory disclosures, public tenders, and audited financial statements across a trailing 6-month capital cycle.

At-a-Glance Health & Momentum Check

Market Mood: Expansionary / Momentum
News Activity
STABLE
Recent announcement pace
Profit & Margin Trend
EXPANDING
Earnings & margin direction
Economy Sensitivity
MODERATE
Impact of rates, oil & FX
Broad Market Mood
Expansionary / Momentum
Current market trend
News Tone
POSITIVE EXPANSION
Recent filing tone
What This Means(based on reported financials)

Recent exchange filings and reported financial statements show healthy alignment between revenue growth, operating cash flow, and improving profit margins.

Active Risk Flags & Monitoring Constraints
Standard systemic equity market and interest rate cycle exposure

Peer & Sector Comparison — Next Research Steps

Exit points and comparative equity universe: same-sector peers, shared macro sensitivity betas, and your watchlist.

Explore All Equities
Same-Sector Peers
Diversified Indian Equities
No direct peers in sector coverage.
Same-Industry Peers
Industry Sub-Segment
No peer equities in this industry.
Also Viewed In Session
Recent History
Start browsing to build your active session footprint.

Common Questions About REKVINA LABORATORIES (VINRKLB)

Key facts on VINRKLB share price, historical returns, valuation ratios, and past SIP performance.

What is the current share price and 52-week range of REKVINA LABORATORIES (VINRKLB)?

As of 16 Oct 2026, the official closing share price of REKVINA LABORATORIES (VINRKLB) on BSE is ₹61.49 (+2.67% vs the previous close). Over the past 52 weeks, VINRKLB has traded between a low of ₹4.50 and a high of ₹61.98, with a reported market capitalization of ₹59.52 Cr.

What are the historical returns of REKVINA LABORATORIES (VINRKLB)?

Based on split-adjusted closing prices through 16 Oct 2026, REKVINA LABORATORIES (VINRKLB) recorded the following trailing price returns: 1 Week: +14.83% (from ₹53.55 to ₹61.49); 15 Days: +23.33% (from ₹49.86 to ₹61.49); 1 Month: +7.52% (from ₹57.19 to ₹61.49); 3 Months: +98.55% (from ₹30.97 to ₹61.49); 6 Months: +45.40% (from ₹42.29 to ₹61.49); 1 Year: +1266.44% (from ₹4.50 to ₹61.49); 3 Years: +1266.44% (from ₹4.50 to ₹61.49); 5 Years: +1330.00% (from ₹4.30 to ₹61.49). Past performance reflects historical exchange records and does not predict future returns.

What is the P/E ratio, P/B ratio, and dividend yield of REKVINA LABORATORIES (VINRKLB)?

REKVINA LABORATORIES (VINRKLB) currently trades at a trailing Price-to-Earnings (P/E) ratio of not applicable (or negative trailing earnings), a Price-to-Book (P/B) ratio of not reported, and a trailing 12-month dividend yield of 0.00%. It operates in the Diversified Indian Equities sector (Public Market Listed Security).

How much would a past lump-sum or monthly SIP investment in VINRKLB have grown?

Based on historical closing prices for REKVINA LABORATORIES (VINRKLB): A one-time lump-sum investment of ₹1,00,000.00 held for 5 years would be worth ₹14,29,999.98 (+1330.0% total return, 70.3% CAGR), while a monthly SIP of ₹10,000.00 over 5 years (total invested: ₹6,10,000.00) would be worth ₹72,86,560.39 (+1094.5% absolute return). You can test custom amounts and holding periods in the interactive calculator above.

Official Corporate Perspective

No authenticated statement registered for VINRKLB.

Authorized Investor Relations officers may submit authenticated context or coordinate with our research team.

Independent exchange feeds and algorithmic models cannot be edited or suppressed by corporate submissions.